말초신경염 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 원인별, 유통경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Peripheral Neuritis Treatment Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.72 Billion in 2025 to USD 5.85 Billion by 2033, growing at a CAGR of 5.82% during the forecast period (2026-2033).

The global peripheral neuritis treatment market includes pharmaceuticals, biologics, and medical devices designed to manage peripheral nerve inflammation, driven by increasing cases of diabetes, autoimmune conditions, and chemotherapy-related neuropathy. The shift from generic analgesics to innovative disease-modifying therapies, such as pregabalin and monoclonal antibodies, reflects rising demand for targeted approaches. The integration of personalized medicine, utilizing genetic profiling for tailored therapies, enhances patient outcomes and encourages expanded insurance coverage, resulting in higher demand for companion diagnostics. AI-driven drug discovery further transforms the landscape, expediting the identification of effective molecular candidates and reducing development timelines. This evolution not only enriches the treatment pipeline with novel agents but also enhances competitive dynamics within the market, presenting significant growth opportunities globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Neuritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Neuritis Treatment Market Segments Analysis

Global peripheral neuritis treatment market is segmented by treatment, cause, distribution, end-user and region. Based on treatment, the market is segmented into Pain Medications (Gabapentin, Pregabalin), Antidepressants (SNRIs, TCAs), Topical Treatments (Lidocaine, Capsaicin) and Physical Therapy. Based on cause, the market is segmented into Diabetic Neuropathy, Chemotherapy-Induced and Idiopathic. Based on distribution, the market is segmented into Retail Pharmacies and Hospital Pharmacies. Based on end-user, the market is segmented into Neurology Clinics and Pain Management Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peripheral Neuritis Treatment Market

The increasing awareness among patients regarding peripheral neuritis is significantly boosting the demand for effective treatment options. As more individuals educate themselves on recognizing symptoms and understanding the necessity of early intervention, there is a substantial rise in the number of patients seeking medical assessments. This shift encourages adherence to prescribed therapies and proactive discussions about treatment alternatives with healthcare professionals, ultimately broadening the pool of patients eligible for advanced therapies. Additionally, the role of patient advocacy organizations in enhancing educational efforts fosters community engagement and encourages proactive health management, further driving the demand for innovative solutions in the treatment of peripheral neuritis.

Restraints in the Global Peripheral Neuritis Treatment Market

The elevated costs associated with new treatments create significant financial obstacles for patients, insurance providers, and healthcare systems, thereby hindering the broader acceptance of advanced therapies for peripheral neuritis. These high prices can trigger stringent reimbursement policies, lengthy prior-authorization requirements, and narrowed formularies, resulting in delayed or denied access for numerous individuals. As a result, healthcare providers may turn to older, less effective treatment options, which stifle the market penetration of innovative products. This economic challenge not only impedes growth potential but also dissuades investment in novel therapeutic developments, ultimately threatening the long-term sustainability of care within this field.

Market Trends of the Global Peripheral Neuritis Treatment Market

The Global Peripheral Neuritis Treatment market is currently experiencing a notable upward trend characterized by the rising adoption of neuroregenerative therapies. Advances in stem-cell engineering and innovative biomaterial scaffolds have facilitated enhanced peripheral nerve regeneration, leading to improved patient outcomes. As clinicians increasingly favor injectable growth-factor cocktails and autologous cell patches for their efficacy in functional recovery and shortened rehabilitation periods, the demand for these treatments is surging. Pharmaceutical companies are responding by diversifying their product pipelines to include these biologics, while advocacy groups amplify awareness of the potential to restore sensation and motor control, further fueling market growth across healthcare systems worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Peripheral Neuritis Treatment Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Pain Medications (Gabapentin, Pregabalin)
• Antidepressants (SNRIs, TCAs)
• Topical Treatments (Lidocaine, Capsaicin)
• Physical Therapy

Global Peripheral Neuritis Treatment Market Size by Cause & CAGR (2026-2033)

• Market Overview
• Diabetic Neuropathy
• Chemotherapy-Induced
• Idiopathic

Global Peripheral Neuritis Treatment Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies

Global Peripheral Neuritis Treatment Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Neurology Clinics
• Pain Management Centers

Global Peripheral Neuritis Treatment Market Size & CAGR (2026-2033)

• North America (Treatment, Cause, Distribution, End-User)
  • US
  • Canada
• Europe (Treatment, Cause, Distribution, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment, Cause, Distribution, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment, Cause, Distribution, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment, Cause, Distribution, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc. (Lyrica/Pregabalin)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly (Cymbalta)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grunenthal GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Spinal Cord Stim)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tonix Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Averitas Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centrexion Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eliem Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chromocell Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations